Back to Search
Start Over
Adjuvant-Protein Conjugate Vaccine with Built-In TLR7 Agonist on S1 Induces Potent Immunity against SARS-CoV‑2 and Variants of Concern.
- Source :
- ACS Infectious Diseases; 7/8/2022, Vol. 8 Issue 7, p1367-1375, 9p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 23738227
- Volume :
- 8
- Issue :
- 7
- Database :
- Supplemental Index
- Journal :
- ACS Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 157890472
- Full Text :
- https://doi.org/10.1021/acsinfecdis.2c00259